Videos2022-07-27T11:23:26-04:00

Videos

Venture capital has become synonymous with innovation. And one firm is turning to an event featuring world renowned artists, actors, athletes and innovators (plus a multi-million-dollar pitch competition) to drive new creative collisions. Toph Day, CEO of Elevate Ventures and mastermind of the Rally Innovation Conference, joins today to talk the state of venture capital, false growth driving bad decisions and his optimism heading into the last quarter of 2024.  

Part of his optimism starts with a major event kicking off in Indianapolis this week – the 2nd Rally Innovation Conference. Toph stresses the value of other vertical perspectives, bringing a wide range of expertise together at Rally and what attendees can expect at the event this week (in one word: Toph says to expect magic). What’s so different about Rally, anyway? Toph acknowledges that innovation doesn’t happen 1 on 1 between investor and entrepreneur and introduces a critical figure to the process: the disparate stakeholder (the figure upon which the event was launched). 

Between the demo floor, nationally renowned keynote speakers and a multi-million-dollar pitch competition, Rally is designed to bring together leaders across multiple disciplines to drive new, creative waves of innovation.   With over 3,000 attendees in year one, Toph has a big vision for Rally’s sophomore season. This includes keynotes from Tia White, Alex Rodriguez, Marcus Lemonis and Jann Mardenborough (think creative collisions) + fantastic breakout sessions across food and agtech (among other verticals).  Learn more about Rally at rallyinnovation.com. Use code RALLYAgrinovus to get 40% off your ticket.

Venture capital has become synonymous with innovation. And one firm is turning to an event featuring world renowned artists, actors, athletes and innovators (plus a multi-million-dollar pitch competition) to drive new creative collisions. Toph Day, CEO of Elevate Ventures and mastermind of the Rally Innovation Conference, joins today to talk the state of venture capital, false growth driving bad decisions and his optimism heading into the last quarter of 2024.

Part of his optimism starts with a major event kicking off in Indianapolis this week – the 2nd Rally Innovation Conference. Toph stresses the value of other vertical perspectives, bringing a wide range of expertise together at Rally and what attendees can expect at the event this week (in one word: Toph says to expect magic). What’s so different about Rally, anyway? Toph acknowledges that innovation doesn’t happen 1 on 1 between investor and entrepreneur and introduces a critical figure to the process: the disparate stakeholder (the figure upon which the event was launched).

Between the demo floor, nationally renowned keynote speakers and a multi-million-dollar pitch competition, Rally is designed to bring together leaders across multiple disciplines to drive new, creative waves of innovation. With over 3,000 attendees in year one, Toph has a big vision for Rally’s sophomore season. This includes keynotes from Tia White, Alex Rodriguez, Marcus Lemonis and Jann Mardenborough (think creative collisions) + fantastic breakout sessions across food and agtech (among other verticals). Learn more about Rally at rallyinnovation.com. Use code RALLYAgrinovus to get 40% off your ticket.

YouTube Video VVVhNGU0WnYzY05pRFFRU25jVlA4NXhRLlpfWkhxTjlTTGk0

317. Toph Day, Elevate Ventures | Agbioscience Podcast

The animal health market – estimated by many sources to be $60 billion globally – spans everything from pet health to livestock and holds applications for innovations in feeds, vaccines, therapeutics and beyond. Joining us this week to talk about this evolving market is Tim Bettington, EVP of Corporate Strategy and Market Development at Elanco, to share his front row view on the evolution of animal health and the driving forces behind its growth. 

Tim talks Elanco’s bifurcation between pet and livestock health, the dynamic challenge of bringing innovation to market in both categories and their unique individual challenges and opportunities. He also gets into investment dollars flowing heavily into the pet space – and how to balance that against innovation in livestock as potential to transform our food system and planet. 

Innovation in livestock has been focused largely on methane reduction in cattle and Tim shares Elanco’s approach to creating products for the animal health space while also giving farmers a pathway to economic and environmental sustainability. Tim talks their partnership with Athian, the launch of Bovaer in the U.S. market and Elanco’s role in the future of the agricultural industry. 

How does Elanco view their balance between internal R&D and external partnerships? Tim dives into the critical role of artificial intelligence (AI) to optimize solutions to problems more quickly and what emerging trends will create a bigger footprint moving forward. He also talks the OneHealth Innovation District coming to Indianapolis, innovating for overall health and what’s ahead.

The animal health market – estimated by many sources to be $60 billion globally – spans everything from pet health to livestock and holds applications for innovations in feeds, vaccines, therapeutics and beyond. Joining us this week to talk about this evolving market is Tim Bettington, EVP of Corporate Strategy and Market Development at Elanco, to share his front row view on the evolution of animal health and the driving forces behind its growth.

Tim talks Elanco’s bifurcation between pet and livestock health, the dynamic challenge of bringing innovation to market in both categories and their unique individual challenges and opportunities. He also gets into investment dollars flowing heavily into the pet space – and how to balance that against innovation in livestock as potential to transform our food system and planet.

Innovation in livestock has been focused largely on methane reduction in cattle and Tim shares Elanco’s approach to creating products for the animal health space while also giving farmers a pathway to economic and environmental sustainability. Tim talks their partnership with Athian, the launch of Bovaer in the U.S. market and Elanco’s role in the future of the agricultural industry.

How does Elanco view their balance between internal R&D and external partnerships? Tim dives into the critical role of artificial intelligence (AI) to optimize solutions to problems more quickly and what emerging trends will create a bigger footprint moving forward. He also talks the OneHealth Innovation District coming to Indianapolis, innovating for overall health and what’s ahead.

YouTube Video VVVhNGU0WnYzY05pRFFRU25jVlA4NXhRLjNHSzRTM1ZvQXBJ

316. Tim Bettington, Elanco | Agbioscience Podcast

Go to Top